RARA CRAFT DATABASE for FDA Medical Devices
510(k)K142201

FDA DEVICE FACTS

OMNI Interface Acetabular System

Omnlife Science

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 26, 2015PRODUCT CODELPH

Indications for use

The OMNI Interface™ Acetabular System is designed to be used in hip arthroplasty. The specific indications for use include -  Non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis;  Rheumatoid arthritis;  Correction of functional deformity;  Congenital dislocation;  Revision procedures where other treatments or devices have failed;  Femoral neck and trochanteric fractures of the proximal femur. The OMNI Interface Acetabular System is intended for cementless and single use implantation only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 6, 2026